Everolimus

NDC 67877-719 · Ascend Laboratories, LLC

Generic nameEverolimus

Dosage formTABLET

RouteORAL

Active ingredient(s)EVEROLIMUS

Strength.5 mg/1

Pharmacologic classCytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Decreased Immunologic Activity [PE], Kinase Inhibitor [EPC], Protein Kinase Inhibitors [MoA], mTOR Inhibitor Immunosuppressant [EPC], mTOR Inhibitors [MoA]

Marketing categoryANDA

Packages

67877-719-31 — 6 BLISTER PACK in 1 CARTON (67877-719-31) / 10 TABLET in 1 BLISTER PACK (67877-719-33)

67877-719-60 — 60 TABLET in 1 BOTTLE (67877-719-60)

Billed under HCPCS

J7527 — Everolimus, oral, 0.25 mg Medicare Part B payment limit (ASP + 6%): $1.16

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

60219-2281 — everolimus, 63850-0058 — Everolimus, 63850-0059 — Everolimus, 63850-0060 — Everolimus, 63850-0061 — Everolimus, 63850-0062 — Everolimus, 63850-0063 — Everolimus, 63850-0064 — Everolimus, 63850-0107 — Everolimus, 67877-718 — Everolimus, 67877-720 — Everolimus, 67877-721 — Everolimus, 70377-010 — everolimus, 70377-011 — everolimus, 70377-012 — everolimus, 70377-013 — everolimus, 70377-069 — Everolimus, 70377-070 — EVEROLIMUS, 70377-071 — everolimus, 70377-090 — Everolimus, +63 more

From the FDA National Drug Code Directory, retrieved 2026-08-24. Product listings are submitted by labelers; FDA does not verify them.